"Blood dialyzer market to exhibit dynamic growth during the forecast period"

The global blood dialyzer market is increasing proficiently, expected to grow at a CAGR of 7.0%. Worldwide, the increasing prevalence of chronic or acute kidney failure and other kidney-related disorders along with hemodialysis (procedure for removal of waste from the blood) procedures will drive the overall growth of the market. Growing awareness about new synthetic membrane technology to overcome the limitations by traditional procedures along with the launch of advanced products with compatible solutions will increase the overall demand in the near future. Increasing popularity of renal replacement therapy, increasing burden of kidney diseases/urinary disorders in the developing nations, rising geriatric population, and rise in the number of U.S. FDA approvals for blood dialyzers  will further spur revenue growth during the forecast period. 

"Synthetic products expected to register higher growth by the end of 2029" 

Advancement in synthetic dialyzer along with the development in the field of membrane materials and biocompatibility will drive the market growth. Non-synthetic membranes types are mainly derived from natural products such as cotton and are less biocompatible compared to synthetic products. For e.g. PSf (polysulfone and a family of polysulfone blends), PES (polyethersulfone), CTA (cellulose triacetate), PMMA (polymethylmethacrylate), PEPA (PES plus polyarylate), EVAL (ethylene vinyl alcohol copolymers) and PAN (polyacrylonitrile). High flux dialyzers will generate maximum revenue share on a global scale. Membranes in the new super high-flux dialyzers are primarily PES and PSf.

"Single use dialyzers to witness a significant CAGR"

Preference for single use dialyzers generated maximum market share in 2020, reusable products may contain the risk of infection and contamination. Moreover, a large patient pool with kidney failure and renal diseases, mainly end stage renal disorder on a global scale will drive the growth globally. Advancement in synthetic membrane technology along with usage of high flux synthetic membranes in dialysis centers and hospitals offers a huge advantage in the global blood dialyzer industry. For e.g. In June 2020, FDA approved Ellipsys Vascular Access System for non-surgical dialysis fistula creation and everlinQ endoAVF receives FDA de novo marketing approval. 

"Increased research and development with strong product pipelines in the developed regions"

Major players in the blood dialyzer market are Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., B. Braun Melsungen AG, Diaverum Deutschland GmbH, NIPRO Medical Corporation, Medica Group, Dialifegroup, Asahi Kasei, NIKKISO CO., LTD., Allmed Medical Care Holdings Limited, Farmasol, Serumwerk Bernburg AG and others. Major enterprises are developing new synthetic technology and advanced biocompatible materials with collective biological solutions. New product launch, partnerships, acquisitions, technology expansion in developing nations and enhanced R&D on blood dialyzers will drive the market growth during the forecast period.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Blood Dialyzer market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Blood Dialyzer market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Blood Dialyzer market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Blood Dialyzer market?
• Which is the largest regional market for Blood Dialyzer market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Blood Dialyzer market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Blood Dialyzer market worldwide?